Don't forget... the 10k only covers thru 7/31. Excellagen was still in samples for most (all?) of Q4. I am VERY anxious to see the 10k, but mostly for the uplist related items.
I don't want to look out too far, with ASM, 10k, and NGIO news in the next month, but I confess I'll be equally excited to see Q1 and get a better feel for Excellagen revs...
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links